4/A
Changes in Ownership
MANNKIND CORP Filed Acc 0001209191-22-047421
EVP Endocrine Business Unit acquired 1,804 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Galindo Alejandro · EVP Endocrine Business Unit
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-01-31 | Grant or award : show line 1 in the form | +1,804 | $3.17 | $5,719 | 539,790 | D |
Loading xslF345X03/doc4a.xml…